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A B ST R A C T
Isoteoline (1ST) has been previously shown to possess anxiolytic activity in models o f  mice and rats. The aim of 
the present study was to exam ine this compound for potential m em ory-im pairing and sedative effects. 1ST 
was compared with scopolam ine and diazepam known for their anterograde amnesia, in respect to informa­
tion acquisition. Diazepam served also as a sedative standard. Passive avoidance test was used to explore the 
effect o f the drugs on the cognitive processes. M emory com ponents such as acquisition, consolidation and re­
trieval were assessed depending on the time o f drugs' adm inistration relative to the training session and the re­
tention session 24h later. W e m easured open field locomotion as an index o f possible sedation. The results 
showed that 1ST was devoid o f  adverse effects on cognition. Unlike diazepam and scopolam ine, 1ST tended to 
improve acquisition. It had no effect on m emory consolidation and retrieval. 1ST did not reduce locomotion as 
well as thus differing from diazepam also in this respect. The lack o f amnesic and sedative effects o f  1ST adds 
favourably to its anxiolytic activity.
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IN T R O D U C T IO N
Isoteoline (1ST) is a glaucine derivative. Early studies with 
this compound have revealed antihypertensive and 
hypotensive activity (2,3,5). Besides 1ST has been shown to 
affect some neuroendocrine and behavioural indices 
through acting on the serotonergic neurotransmission
(21,24,25). Among these, 1ST has been demonstrated to 
possess anxiolytic-like activity in mice subjected to the 
light-dark choice procedure (4) and in rats examined in the 
social interaction test (22). As with most o f  the other effects 
o f 1ST, the anxiolytic effect is supposed to be due to 
5-HT2C receptors blockade. In addition, microdialysis ex­
periments have shown 1ST to increase the release o f acetyl­
choline from hippocampus of freely moving rats, and at the 
same time to inhibit the release evoked by mCPP through 
stimulation o f 5-HT2C receptors (23).
Taking into account the anxiolytic activity o f 1ST and the 
last findings mentioned, it was attempted to answer the 
question whether 1ST would adversely affect memory and 
learning. In addition, having in mind another side effect of 
benzodiazepines - the sedative one, it was o f interest to 
check if  1ST possessed the capacity o f inducing sedation.
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Thus the aim of the present study was to assess the behav­
iour of 1ST in experimental tests detecting memory impair­
ment and sedation. Diazepam and scopolamine were used 
as amnestic comparator drugs and diazepam served also as 
a sedation-causing agent.
M A T E R IA L  A N D  M E T H O D S
Animals
Male white mice weighing 25-40g were used, divided in 
groups of 5-10. The animals were kept under standard con­
ditions in the animal house with a 12:12 light:dark period 
and had their usual access to food and water.
Methods
1. A single trial passive avoidance (PA) test was used to 
study the substances' effects on the cognitive functions in 
mice. We made use o f a PA device constructed according 
to a modified procedure, in which the painful punishment 
(foot-shock) was replaced by a non-painful one (11). This 
represented a wooden box made o f two chambers - a light 
one and a dark one. The two chambers communicated 
through a small hole allowing the free passage o f the 
mouse. The dark chamber had a floor consisting of two 
wings, whose quick opening downwards caused the mouse 
to fall into cold water immediately after stepping into the 
chamber.
The mouse was gently placed in the center o f the light 
chamber. After a few ambulations, the animal made him­
self to the dark compartment. On stepping there, the mouse 
was subjected to the stress o f a sudden fall in cold water.
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The latency (in seconds) was recorded from the moment of 
entering the light chamber till the moment o f  leaving it by 
stepping into the dark compartment with all the four paws. 
After accomplishing the first, training session (Tl), the test 
was repeated 24h later (retention session, T2), during which 
the same latencies were recorded without applying punish­
ment.
Control mice had a significant prolongation of the T2 rela­
tive to Tl latencies, as a result o f memory retention. 
Shortening o f  T2 in respect to control values marked im­
pairment of cognitive functions and vice versa Which cog­
nitive process was particularly affected - acquisition, mem­
ory consolidation or retrieval, depended on the time when 
the drug treatment was given (8). Treating the animal be­
fore punishment was indicative o f changes in learning or 
acquisition. Giving the drug immediately after the training 
session reflected the consolidation process. Finally, drug 
administration immediately prior to the retention session 
was used to get information about the retrieval process.
2. Open field test was used to study the locomotion o f mice. 
Animals were gently placed in the center o f an arena with 
dimensions o f 60x60cm, the white floor o f which was di­
vided by black lines in 9 quadrates o f 20x20cm. The loco­
motor activity was measured by counting the number o f  the 
lines crossed by the animal during 5-min sessions. The 
hypolocomotion was considered a measure o f sedation. 
Drugs
Isoteoline hydrobromide has been synthesized in the De­
partment of Pharmacology o f the Higher Medical Institute 
o f Varna (1). It was used at a dose o f 4mg/kg, which has 
been effective as anxiolytic one both in mice and in rats (4, 
22). Diazepam (Sopharma) was used at dose of 2mg/kg and 
scopolamine hydrobromide (Sopharma) - at a dose of 
1 mg/kg. The doses o f scopolamine and diazepam were se­
lected from the literature as effective doses in the mouse PA 
paradigm (7,18).
Statistics
The results were represented as a mean +SEM and the 
means were compared by Student's t-test. GraphPad Prism 
software was used.
Fig. 1. A. Effect o f  drugs on information acquisition.
The drugs were injected i.p. 30 min before Tl. Effect o f  
1ST (4 mg/kg, i.p.); *p<0,05, **p<0,01 vs. control
R E SU L T S A N D  D ISC U SSIO N
The effects on acquisition of the drugs studied were as fol­
lows: 1ST (4mg/kg), given by intraperitoneal (i.p.) route 
30min before the training session, slightly prolonged the 
T2-latency (p=0,2537 vs. control) (Fig. 1A). Under the 
same conditions diazepam (2mg/kg, i.p.) and scopolamine 
(1 mg/kg, i.p.) caused significantly shorter T2-latencies 
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Fig. I. B. Effect o f  drugs on information acquisition.
The drugs were injected i.p. 30 min before Tl. Effects o f  
diazepam (2 mg/kg, i.p.) and scopolamine (1 mg/kg, i.p.) 
*p<0,05, **p<0,01 vs. control
In the test for memory consolidation 1ST treatment was 
given immediately after the training session. It resulted in a 
retention latency that was insignificantly shorter in respect 
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Fig. 2. Effect o f  IST (4 mg/kg, i.p.) on memory 
consolidation. The drug was injected i.p. immediately 
after T l
In the experiment for memory retrieval 1ST was adminis­
tered 30min before the retention session. There was no dif­
ference between the T2-latency values o f IST-treated and 
control mice (p=0,8376) (Fig. 3).
In the open field test 1ST caused no change in the horizontal 
locomotion (p=0,678 vs. controls), while diazepam signifi­
cantly decreased the number o f lines crossed in 5min 
(p=0,0261) (Fig. 4).
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Training (T1 ) Retention (T2)
Fig. 3. Effect o f  1ST (4 mg/kg, i.p.) on memory retrieval. 
The drug was injected i.p. 30 min before T2
The results o f the present experiments showed that at a dose 
endowed with anxiolytic activity 1ST did not produce cog­
nitive deficits. The lack o f memory impairment was partic­
ularly prominent when comparing 1ST with diazepam and 
scopolamine in the sub-test of learning or acquisition. 
These drugs are long known for the anterograde amnesia 
that they induce both clinically and experimentally 
(6,7,10,12,17,18,19). This amnestic effect was confirmed 
in our experiments by the significant reduction of the reten­
tion latencies when the drugs were given prior to the train­
ing session. On the contrary, 1ST in the same schedule 
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Fig. 4. Effect o f  IST (4 mg/kg, i.p.) and diazepam (2 
mg/kg, i.p.) on open f ie ld  locomotion *p<0.05 vs. 
control
It is well known that the central cholinergic system is impli­
cated in memory and learning (13 and others). The 
amnestic effect o f scopolamine is mediated by blockade of 
central muscarinic receptors. The memory-impairing effect 
o f diazepam has been shown to depend on specific benzo­
diazepine receptors on the GABA-ionophore complex, as 
well as on other neurotransmitter systems (9,20). At least in 
part, it is mediated by inhibition of the central cholinergic 
neurotransmission, being prevented by anticholinesterase 
drugs and compounds increasing the release of acetylcho­
line (6,7,16). We could thus speculate that the observed ten­
dency of 1ST to improve learning in the PA paradigm might 
be due to its effect of enhancing central cholinergic 
neurotransmission (23). However, 1ST has also been found 
to antagonize the 5-HT2C receptor-mediated increase in 
acetylcholine efflux in hippocampus (23), which might ac­
count for the failure o f the compound to reach statistically 
significant enhancement o f acquisition. As far as the 
serotonergic system is concerned, it is also known to affect 
cognitive processes (14). Multiple 5-HT receptors are in­
volved in PA with roles that probably differ at various 
stages of information processing ( 15). It has been tradition­
ally accepted that 5-HT2A/2C receptor blockade improves 
learning ( 14), but due to the relative lack of selective ligands 
discriminating between the two receptors, the exact contri­
bution o f each o f them is still poorly defined. Still, an im­
portant regulatory role was suggested for the 5-HT2C re­
ceptor based on the ability o f a selective 5-HT2C receptor 
antagonist, Ro 60-0491, to reverse the memory-impairing 
effect of mCPP when injected before training (15). Since 
1ST has the potential o f antagonizing 5-HT2C receptors
(4,21,24,25), this action could also be involved in the effect 
on learning. Thus 1ST may influence PA acquisition in a 
complex manner, by different and perhaps opposing mech­
anisms, resulting finally in a small positive answer.
On the other hand, 1ST did not significantly affect the pro­
cesses o f memory consolidation. There was a slight insig­
nificant tendency to impair the retention performance. Ac­
cording to some literature data, there are 5-HT2A/2C an­
tagonists that improve memory storage and others that do 
not [14]. 1ST had no effect on retrieval as well, as assessed 
by the PA task.
1ST induced no sedation according to the results in the open 
field test In this respect it differed from diazepam, which 
typically induced locomotor depression, indicative of seda­
tive effect.
In conclusion, the lack o f negative results on memory and 
the absence of sedation at effective doses favorably add to 
the anxiolytic activity o f 1ST in mice and rats. Thus the 
present study provides evidence o f 1ST being an experi­
mental anxiolytic agent with promising and favorable ad­
verse effects profile as compared with the clinically used 
benzodiazepines.
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